| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99233 |
Prolong inpt eval add15 m |
14,336 |
5,569 |
$305K |
| 99223 |
Prolong inpt eval add15 m |
3,992 |
3,870 |
$219K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
6,116 |
5,963 |
$200K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
9,692 |
2,894 |
$136K |
| 94729 |
|
2,888 |
2,877 |
$37K |
| 94726 |
|
2,890 |
2,880 |
$36K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,141 |
1,139 |
$36K |
| 94060 |
|
2,906 |
2,896 |
$33K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
710 |
710 |
$27K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,637 |
1,599 |
$24K |
| A4604 |
Tubing with integrated heating element for use with positive airway pressure device |
1,423 |
1,359 |
$14K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
2,671 |
2,658 |
$5K |
| 94664 |
|
2,318 |
2,309 |
$4K |
| 99254 |
|
52 |
51 |
$2K |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
2,071 |
2,065 |
$78.06 |
| 94618 |
|
30 |
29 |
$0.00 |
| 99448 |
|
15 |
15 |
$0.00 |